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Abstract
Endogenous retroviruses (ERVs) constitute approximately 8–10% of the human and mouse genome. Some autoimmune diseases are attributed
to the altered expression of ERVs. In this study, we examined the ERV expression profiles in lymphoid tissues and analyzed their biological
properties. Tissues (spleen, thymus, and lymph nodes [axillary, inguinal, and mesenteric]) from C57BL/6J mice were analyzed for differential
murine ERV (MuERV) expression by RT-PCR examination of polymorphic U3 sequences. Each tissue had a unique profile of MuERVexpression.
A genomic map identifying 60 putative MuERVs was established using 22 unique U3s as probes and their biological properties (primer binding
site, coding potential, transcription regulatory element, tropism, recombination event, and integration age) were characterized. Interestingly, 12
putative MuERVs retained intact coding potentials for all three polypeptides essential for virus assembly and replication. We suggest that MuERV
expression is differentially regulated in conjunction with the transcriptional environment of individual lymphoid tissues.
© 2007 Elsevier Inc. All rights reserved.Keywords: Endogenous retrovirus; Spleen; Thymus; Lymph node; Coding potential; Transcription; GenomeIntroduction
Infection of germline cells with retroviruses leads to their
permanent colonization into the germline genome. These germ-
line-integrated retroviruses are transmitted vertically to the
offspring in a Mendelian fashion and are called endogenous
retroviruses (ERVs), in contrast to exogenous retroviruses, which
are acquired from external surroundings and transmitted hori-
zontally. ERVs represent collections of retroviral proviruses in-
troduced into the germline and accumulated throughout an entire
set of generations.
ERVs and other forms of transposable repetitive elements
make up ∼45% of the human and mouse genomes (Urnovitz
and Murphy, 1996). Among them, ∼8% of the human genome
and ∼10% of the mouse genome consist of ERVs (Griffiths,
2001; Lander et al., 2001; Waterston et al., 2002). Although the
majority of ERVs are defective primarily due to deletions and⁎ Corresponding author. Fax: +1 916 453 2288.
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doi:10.1016/j.virol.2007.10.043point mutations leading to a disruption of the coding potential of
the gag, pol, and/or env genes, some are characterized to be
biologically active.
Most ERVs have the potential to modulate the expression of
host genes near the integration site, for example, the transcrip-
tional control of the amylase gene in the salivary gland
(Samuelson et al., 1996). The HTDV (human teratocarcinoma-
derived virus), a member of the human ERV (HERV)-K family,
produces type C retroviral particles and retains the coding
potential for retroviral polypeptides essential for virus assembly
and replication (Knossl et al., 1999; Lower et al., 1993). The
HTDV U3 promoter is highly specific for the transcriptional
environment in testicular tumor cells (Lower et al., 1996).
Furthermore, the pathogenic processes of certain autoim-
mune diseases, such as systemic lupus erythematosus, insulin-
dependent diabetes mellitus, and multiple sclerosis, have been
associated with altered expression of ERVs (Conrad et al., 1997;
Deas et al., 1998; Wang et al., 2001). In particular, expression of
the HERV-W encoded envelope glycoprotein, called syncytin,
was increased in the brain of multiple sclerosis patients (Antony
et al., 2004). Syncytin expression in astrocytes was responsible
for neuroinflammation, resulting in demyelination and the death
Fig. 1. RT-PCR analyses of the MuERVexpression profiles in various lymphoid
tissues. Five different lymphoid tissues (spleen, thymus, lymph nodes [axillary,
inguinal, and mesenteric]) from C57BL/6J mice were subjected to RT-PCR
analysis of MuERV expression using the primer set (ERV-U1 and ERV-U2).
Tissue-specific MuERV expression profile is evident. Four different fragments
from each tissue, which were subjected to further analyses, are indicated (I, II,
III, and IV). The genomic MuERV U3 profile serves as a reference. Bottom
panel depicts locations of primers on a schematic MuERV.
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cytin demonstrated a unique role of an ERV protein in a path-
ologic process in humans. In addition, recent studies from our
laboratory provide evidence that burn-elicited stress signals can
alter the transcriptional activities of certain murine ERVs
(MuERVs) in distant organs of mice (Aziz et al., 1989; Cho
et al., 2002; Cho and Greenhalgh, 2003). Interestingly, some of
these burn-elicited MuERVs are structurally similar to the
MAIDS (murine acquired immunodeficiency syndrome)-
inducing virus.
It is likely that the unique transcriptional environment in each
cell or tissue type directly influences the MuERV expression
profile. The genome-wide distribution of MuERVs and their
differential expression in various types of tissues and cells may
be directly networked to a vast range of signaling events con-
trolling normal physiologic as well as pathologic processes. Two
main types of MuERVs, murine leukemia virus (MuLV) and
mouse mammary tumor virus (MMTV), are reported to be
involved in various pathophysiologic processes involving im-
mune organs (Choi et al., 1987; King and Corley, 1990). In this
study, we examined the MuERV expression profiles in various
lymphoid tissues of mice and characterized their biological
properties.
Results
Differential expression of MuERVs among various lymphoid
tissues
We postulate that MuERV expression profiles vary depend-
ing on tissue type mainly due to the unique composition of the
transcriptional environment within the diverse cell populations
comprising each tissue. In this study, the MuERV expression
profile in five different lymphoid tissues (spleen, thymus, and
lymph nodes [axillary, inguinal, and mesenteric]) were exam-
ined in female C57BL/6J mice. The NCBI (National Center for
Biotechnology Information) mouse genome database, which is
derived from the C57BL/6J strain, was used for comparative
analysis. RT-PCR analyses of the MuERV expression profiles
were performed by amplifying the polymorphic U3 region
within the 3′ long terminal repeats (LTRs). Electrophoretic
analysis of amplified U3 products revealed a unique MuERV
expression profile within each lymphoid tissue examined
(Fig. 1). There were variations in the length (ranging from
∼470 bp to ∼750 bp) as well as in the intensity of amplified
MuERV U3s. Interestingly, the genomic MuERV profile (size
and intensity of amplified U3s) was substantially different from
the expression profiles of all lymphoid tissues examined. Only
four different MuERV U3 fragments (labeled as I, II, III, and
IV), which were present in all five tissues, were selected for a
direct comparison of differential expression levels followed by
downstream characterization of biological properties. Further
investigation into the other MuERV U3 fragments, which were
presumed to be derived from certain MuERVs expressed only in
some tissues examined, may provide additional information in
regard to differential expression of MuERVs in lymphoid
tissues.Multiple alignment and phylogenetic analyses of differentially
expressed MuERV U3 sequences
Cloning and sequencing analyses of four different U3 frag-
ments (I, II, III, and IV) from all five lymphoid tissues yielded
43 MuERV U3 sequences which represent at least two se-
quences from each fragment (Fig. 2A). These U3 sequences
were subjected to multiple alignment and phylogenetic
analyses. Since the amplified U3 regions include ∼117 bp
upstream and downstream of the exact U3 sequence, these
additional nucleotides were trimmed prior to the alignment
analyses. The initial multiple alignment analysis yielded 22
unique U3s (24 U3s are shown to include at least one sequence
from each fragment) (Fig. 2B). The U3 sequences were
apparently grouped into six main branches coinciding with
the differences in their sizes (ranging from 346 bp to 601 bp)
(Fig. 2A). In addition, the Th(IV)-1 U3 sequence formed a
unique branch, which is consistent with its unique size of 392 bp
and absence of a direct repeat (1/1⁎) (Fig. 2B), although it had
high sequence similarities with the branches of Th(III)-1 and
mLN(IV)-2. Multiple alignment of the 24 unique U3 sequences
revealed that both the 5′-end and 3′-end were well-conserved
and the middle region, which includes a single 190 bp insertion,
was hypervariable (Fig. 2B). It has been established that the
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specific sequence features (e.g., direct repeat, unique region)
within the U3 promoter (Tomonaga and Coffin, 1998; Tomonaga
and Coffin, 1999). Putative cellular tropisms of the unique U3
sequences were determined by the examination of four direct
repeat regions (1/1⁎, 4/4⁎, 5/5⁎, and 6/6⁎), a single 190 bp
insertion, and two unique regions (2 and 3) (Fig. 2B and Table 1).
There were 15 xenotropic and nine polytropic/modified poly-
tropic U3 sequences.
Profile of transcription regulatory elements on individual
MuERV U3 promoters
It is expected that the 3′ U3 sequences are almost identical to
the 5′ U3 sequences, the latter which serve as promoters. To
examine the transcription potential of the 22 unique MuERV U3Fig. 2. A: Phylogenetic analysis of differentially expressed MuERV U3 sequence
established. The confidence values at the branch nodes represent the percentage suppo
tissues. Sp (spleen), Th (thymus), aLN (axillary lymph node), iLN (inguinal lym
differentially expressed MuERV U3 sequences. Differentially expressed MuERV U3
U3 sequences. Yellow (100% homology), white (low homology), blue (conserved s
(1/1⁎, 4/4⁎, 5/5⁎, and 6/6⁎), unique regions (2 and 3), and TATA box are indicatesequences (3′ U3s), the putative transcription regulatory ele-
ments were mapped on each U3 (Table 2). Only the tran-
scription regulatory elements with a core similarity (compared
to conserved sequences) of greater than 90% were selected. This
mapping study yielded 71 transcription regulatory elements,
which included binding sites for the glucocorticoid receptor and
NF-κB. Although some elements were shared by the majority of
the U3 sequences examined, other elements were unique to
certain U3 promoters. For instance, a glucocorticoid response
element (GRE), binding site for glucocorticoid receptor (high-
lighted with ⁎), was present only in the iLN(II)-2 U3 promoter.
A binding site for signal transducers and activators of tran-
scription 3 (STAT3) (highlighted with ⁎) was mapped only in
the Th(IV)-1 U3 promoter. It will be of interest to test whether
the putative GRE responds to stimulation by glucocorticoids in
vitro and in vivo. On the other hand, a binding site for NF-κBs. A phylogenetic tree of differentially expressed MuERV U3 sequences was
rt of a particular branching. Various colored shapes represent different lymphoid
ph node), mLN (mesenteric lymph node). B: Multiple alignment analysis of
sequences were subjected to a multiple alignment analysis and yielded 22 unique
equences), and dash (absence of sequences). The locations of the direct repeats
d in dotted boxes. An insertion of 190 bp is identified in the middle.
Fig. 2 (continued ).
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inflammatory response, was identified in five different U3
promoters (Th(IV)-1, Th(I)-2, iLN(I)-1, Sp(I)-2, and aLN(I)-1).The unique profiles of transcription regulatory elements on each
U3 promoter suggest their differential transcription potentials in
a given transcriptional environment.
Table 1
Tropism analysis of 22 unique MuERV U3 sequences isolated from five different lymphoid tissues
U3s Direct repeat/unique region Tropism
1/1⁎ 2 3 4/4⁎ 5/5⁎ 6/6⁎
iLN(V)-1 X-II, X-III X-I, X-II, X-IV, P-II, P-III, P-V d X-III d X-I, X-II, X-III, X-IV, Poly X-III
Sp(V)-1 X-II, X-III X-I, X-II, X-IV, P-II, P-III, P-V d X-III d X-I, X-II, X-III, X-IV, Poly X-III
aLN(V)-1 X-II, X-III X-I, X-II, X-IV, P-II, P-III, P-V d X-III d X-I, X-II, X-III, X-IV, Poly X-III
mLN(V)-1 X-II, X-III . d X-III d X-I, X-II, X-III, X-IV, Poly X-III
Th(V)-1 X-II, X-III X-I, X-II, X-IV, P-II, P-III, P-V d X-III d X-I, X-II, X-III, X-IV, Poly X-III
Th(III)-1 X-II, X-III X-III, P-I, P-IV d X-II, X-IV X-II, X-III, X-IV, P-I, P-IV X-I, X-II, X-III X-II
iLN(III)-1 X-II, X-III X-III, P-I, P-IV d X-II, X-IV X-II, X-III, X-IV, P-I, P-IV X-I, X-II, X-III X-II
Th(III)-2 X-II, X-III X-III, P-I, P-IV d X-II, X-IV X-II, X-III, X-IV, P-I, P-IV X-I, X-II, X-III X-II
mLN(IV)-2 X-III X-I, X-II, X-IV, P-II, P-III, P-V Xeno/Poly/mPoly X-II X-II, X-III, X-IV, P-I, P-IV X-I, X-II, X-III, X-IV, Poly X-II
Sp(IV)-1 X-III X-I, X-II, X-IV, P-II, P-III, P-V Xeno/Poly/mPoly X-II X-II, X-III, X-IV, P-I, P-IV X-I, X-II, X-III, X-IV, Poly X-II
mLN(III)-1 X-III X-I, X-II, X-IV, P-II, P-III, P-V Xeno/Poly/mPoly X-II X-II, X-III, X-IV, P-I, P-IV X-I, X-II, X-III, X-IV, Poly X-II
mLN(IV)-1 X-III · Xeno/Poly/mPoly X-II X-II, X-III, X-IV, P-I, P-IV X-I, X-II, X-III, X-IV, Poly X-II
mLN(III)-2 X-III X-I, X-II, X-IV, P-II, P-III, P-V Xeno/Poly/mPoly X-II X-II, X-III, X-IV, P-I, P-IV X-I, X-II, X-III, X-IV, Poly X-II
aLN(IV)-1 X-III X-I, X-II, X-IV, P-II, P-III, P-V Xeno/Poly/mPoly X-II X-II, X-III, X-IV, P-I, P-IV X-I, X-II, X-III, X-IV, Poly X-II
iLN(IV)-2 X-III X-I, X-II, X-IV, P-II, P-III, P-V Xeno/Poly/mPoly X-II X-II, X-III, X-IV, P-I, P-IV X-I, X-II, X-III, X-IV, Poly X-II
Th(IV)-1 · X-I, X-II, X-IV, P-II, P-III, P-V Xeno/Poly/mPoly P-IV X-II, X-III, X-IV, P-I, P-IV X-I, X-II, X-III, X-IV, Poly P-IV
Th(I)-2 P-II, P-III X-I, X-II, X-IV, P-II, P-III, P-V Xeno/Poly/mPoly P-II P-I, P-II, P-III P-II P-II
iLN(I)-1 P-II, P-III X-I, X-II, X-IV, P-II, P-III, P-V Xeno/Poly/mPoly P-II P-I, P-II, P-III P-II P-II
Sp(I)-2 P-II, P-III X-I, X-II, X-IV, P-II, P-III, P-V Xeno/Poly/mPoly P-II P-I, P-II, P-III P-II P-II
aLN(I)-1 P-II, P-III X-I, X-II, X-IV, P-II, P-III, P-V Xeno/Poly/mPoly P-II P-I, P-II, P-III P-II P-II
Th(II)-1 P-I X-III, P-I, P-IV Xeno/Poly/mPoly P-I P-I, P-II, P-III X-I, X-II, X-III, X-IV, Poly P-I
iLN(IV)-2 P-I X-III, P-I, P-IV Xeno/Poly/mPoly P-I P-I, P-II, P-III X-I, X-II, X-III, X-IV, Poly P-I
mLN(I)-2 P-I X-III, P-I, P-IV Xeno/Poly/mPoly P-I P-I, P-II, P-III X-I, X-II, X-III, X-IV, Poly P-I
aLN(II)-1 P-I X-III, P-I, P-IV Xeno/Poly/mPoly P-I P-I, P-II, P-III X-I, X-II, X-III, X-IV, Poly P-I
Dot indicates absence of a homology to reference sequences. Underscore represents the reference type closest to the individual U3 sequences examined. ⁎Direct repeat
region.
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sequences as a probe and characterization of their biological
properties
Genomic localization of putative MuERVs
In order to investigate the genome-wide distribution of
MuERVs harboring the U3 sequences identified in various lym-
phoid tissues, theNCBImouse genome databasewas probedwith
individual U3 sequences. Subsequently, the putative MuERVs
with a homology of greater than 98% relative to the U3 probe and
approximately 5 kb to 9 kb in size were selected for further
analyses (Table 3). The defective MuERVs with substantial
deletions in pol and env genes tend to be approximately 5 kb and
the full-length MuERVs are about 9 kb. Genomic probing using
the 22 unique U3 sequences revealed 60 defective or full-length
MuERVs dispersed throughout the entire genome in both strands
except for on chromosomes 17 and Y. Chromosomal location,
including proviral size and strand orientation, of these putative
MuERVs are summarized in Table 3.
Open reading frame (ORF)
The structures of the putativeMuERVs identified in this study
were determined by comparison to full-length murine leukemia
virus (MuLV) reference sequences (GenBank accession nos.
AF033811 and DQ241301). ORF analyses revealed that 12 of
the 60 putative MuERVs were full-length and had intact coding
potentials for all three retroviral polypeptides (gag, pol, and env)
(highlighted in gray, Table 3). Six putativeMuERVs (highlighted
in yellow) had an insertion of a nucleotide (cytosine) withinvarious poly C regions resulting in a defective gag polypeptide
due to an insertional frame shift. The locations (nucleotide
number from the 5′-end of the provirus) of the insertions within
these MuERVs are indicated in parentheses: Th(I)-2a 99%
(1,700), Th(I)-2b 98% (1,701), aLN(II)-1a 99% (1,738), Th(II)-
1a 100% (1,657), aLN(II)-1p 99% (1,738), and aLN(II)-1h 99%
(1,657). On the other hand, putative MuERV Th(I)-2g 99% had
a deletion of a cytosine at 1,657 resulting in a frameshift of the
gag polypeptide. It is possible that the insertion or deletion of a
single cytosine in the poly C regions may be attributable
to a sequencing error in the NCBI database. In addition,
“ATG→GTG” mutations were observed in 26 putative
MuERVs (highlighted in blue, Table 3) at the first start codon
(ATG) of the reverse transcriptase (RT) region within the pol
gene, resulting in a loss of three amino acids from the start of
the RT protein. The putative MuERV Th(II)-1r 99% contains a
green box under the gag column because the gag ORF was
deemed complete, despite the one amino acid deletion within
the p12 region.
Primer binding site (PBS)
Analyses of PBSs for all 60 putative MuERVs revealed that
59 proviruses contained a glutamine (Q) tRNA binding site,
while the Th(IV)-1a 100% putative MuERV contained a proline
(P) tRNA binding site (Table 3).
Recombination event and integration age
Only 6 out of 60 putative MuERVs had LTR mutations
(5′ LTR sequence compared to 3′ LTR sequence) ranging from
Table 2
Transcription regulatory elements in 22 unique MuERV U3 promoter sequences isolated from five different lymphoid tissues
The number in the box indicates frequency of a transcriptional regulatory element within a given U3 promoter sequence, and the gray box indicates no occurrence of the specific transcriptional regulatory element.














In silico cloning and biological properties of putative MuERVs differentially expressed in lymphoid tissues
Gray indicates putative full-length MuERVs. Two putative MuERVs mapped by only one U3 probe are highlighted in purple. Absence of direct repeat sequences is
indicated with “/” between two sequences. Yellow indicates putative MuERVs with a cytosine insertion. Blue indicates putative MuERVs with ATG→GTG mutation
at the RT start site. Green indicates that the gag was considered intact despite one amino acid deletion within p12. PBS (primer binding site): P (tRNAproline) and
Q (tRNAglutamine). ND (not determined). Coding potential: intact (+), partial (P), and defective (−). NA (lacking a proper start codon).
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MuERV had a deletion of 39 nucleotides in the middle of the
5′ LTR in comparison to its 3′ counterpart and the mutation rate
was not calculated. The integration age of these MuERVs was
calculated (ranging from 1.038 million years [MYr] to 2.2072
MYr) based on a formula of “0.13% mutation rate between two
flankingLTRs/oneMYr” (Sverdlov, 2000). To determinewhether
there were genetic rearrangements by recombination during the
lifespan of the putative MuERVs, we examined the presence or
absence of a direct repeat sequence flanking both ends of the
proviral sequences. Direct repeats are formed during initial inte-
gration of proviruses and any downstream recombination events
result in two unique sequences instead. There were 10 putative
MuERVs with unique sequences flanking the integration sites,
suggesting recombination events, and the rest had direct repeats
of four nucleotides (49 putative MuERVs) or 12 nucleotides (one
putative MuERV: aLN(II)-1h 99%) (Table 3).
Tropism analysis by restriction fragment length polymorphism
(RFLP)
Cellular tropisms of 12 full-length putative MuERVs with
intact coding potentials were determined by in silico RFLP
using three restriction enzymes (BamHI, EcoRI, and HindIII)
(Stoye and Coffin, 1988). It revealed six polytropic and six
modified polytropic putative MuERVs (Fig. 3). It needs to be
noted that although the putative tropism traits described in
this study are likely to be correct, it may be necessary to
determine each MuERV's tropism by an in vitro infection
study.Fig. 3. RFLP tropism analysis of the putative full-length MuERVs with intact coding
by in silico RFLP analysis using three restriction enzymes (BamHI, EcoRI, and HinDiscussion
The findings from this study demonstrated that certain
MuERVs were actively transcribed and their expression profiles
were specific for each lymphoid tissue examined. Further
studies may be necessary to determine the MuERV expression
profile in various subsets of cells within each lymphoid tissue.
Individual lymphoid tissues and cell types are presumed to have
unique characteristics specific to their transcriptional environ-
ment, such as transcription factor pool (Schon et al., 2001; van
Opijnen et al., 2004). Considering the tissue and cell type-
specific transcription factor pool, in conjunction with the unique
set of transcription regulatory elements within each MuERV U3
promoter, the findings of differential MuERV expression in
various lymphoid tissues in this study are readily predictable.
Moreover, the transcription factor profile within each tissue or
cell type is affected by its own pathophysiologic status and the
surrounding environment, such as systemic immune modulation
and carcinogenesis (Boral et al., 1989).
Due to the polymorphic nature of the MuERV U3 sequences,
each U3 promoter is likely to harbor a unique transcription
potential, primarily determined by its profile of binding sites for
transcription factors. It suggests that changes in the transcription
environment due to stress (e.g., injury, infection) will lead to
differential expression of certain MuERVs in different tissues.
The viral gene products and viral replication itself associated
with the altered MuERV expression may participate in a range
of pathophysiologic activities in a tissue- and cell type-specific
manner.potentials. Cellular tropisms of 12 putative full-length MuERVs were determined
dIII). Each restriction site is indicated in parenthesis on schematic MuERVs.
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C57BL/6J strain using the U3 sequences as a probe allowed us to
characterize their biological properties such as coding potential,
replication competency, and tropism. The results from this study
demonstrated that some of the putative MuERVs are full-length
with intact ORFs for the gag, pol, and env genes and are pre-
sumably replication-competent. Further functional characteriza-
tion of these putativeMuERVs is essential to understanding their
roles in normal physiology and pathology of individual lym-
phoid tissues and cells. In particular, the putative MuERVs
retaining intact coding potentials for gag, pol, and/or env may
be cloned from the C57BL/6J genome into an expression vector
for functional analyses in vitro (e.g., cell tropism, viral gene
expression, cytokine production, cytotoxicity) and in vivo (e.g.,
infection of virions into mice followed by examination of their
effects on the immune system). In addition, the biological pro-
perties of individual gene products, primarily gag and env
proteins, from each putative MuERV may be investigated in
vitro using overexpression as well as knock-out protocols.
Retroviral U3 promoters are capable of controlling the ex-
pression of host genes adjacent to the integration sites through
certain transcription regulatory elements, such as enhancers and
negative regulatory elements (Trusko et al., 1989; Yu et al.,
2005). It will be of interest to investigate whether the U3 pro-
moters of putative MuERVs identified in this study play a role in
the transcriptional activities of neighboring host genes.
It may be reasonable to postulate that MuERVs, distributed
throughout the genome, play crucial and differential roles in
normal physiologic and pathologic processes in various lym-
phoid tissues and cells. The specificity of MuERVexpression is
primarily dependent upon the polymorphic U3 promoter se-
quences and the specific transcriptional environment in each
tissue/cell type. Understanding the biological characteristics of
tissue-specific MuERVs and their relationship with neighboring
genes will broaden insight into their roles in a range of patho-




Female C57BL/6J mice from Jackson Laboratories (Bar
Harbor, ME) were housed according to the guidelines of the
National Institutes of Health. The Animal Use and Care Ad-
ministrative Advisory Committee of the University of Califor-
nia, Davis, approved the experimental protocol. Threemicewere
sacrificed by cervical dislocation for lymphoid tissue collection
without any pretreatments.
RT-PCR analysis
Total RNA isolation and cDNA synthesis were performed
based on protocols described previously (Cho et al., 2000).
Briefly, total RNA was extracted using a RNeasy kit (Qiagen,
Valencia, CA). Total RNA (100 ng) from each tissue sample
was subjected to reverse transcription. The sequence of theoligo-dT primer was as follows: 5′-GGC CAC GCG TCG ACT
AGTACT TTT TTT TTT TTT TTT T-3′. Primers, ERV-U1 (5′-
CGG GCG ACT CAG TCTATC GG-3′) and ERV-U2 (5′-CAG
TAT CAC CAA CTC AAATC-3′) were used to amplify the U3
regions of nonecotropic MuERVs. The primers for β-actin
amplification were 5′-CCA ACT GGG ACG TGG AA-3′ and
5′-GTA GAT GGG CAC AGT GTG GG-3′. The comparability
between samples was determined by both the electrophoresis
of an equal amount (500 ng) of total RNA and the RT-PCR
amplification of β-actin from each sample.
Cloning of MuERV U3 sequences
PCR products were gel purified using the QIAquick Gel
Extraction kit (Qiagen) and cloned into the pGEMT-Easy vector
(Promega,Madison,WI). PlasmidDNAs for sequencing analysis
were prepared using a miniplasmid kit from Qiagen. Sequencing
was performed at Davis Sequencing Inc. (Davis, CA).
Multiple alignment and phylogenetic tree analysis
The resulting 43 MuERV U3 sequences were aligned using
Vector NTI Advance 10 (Invitrogen, Carlsbad, CA) program to
identify unique U3 sequences. A phylogentic tree was obtained
using the neighbor-joining protocol within the MEGA3 pro-
gram (Kumar et al., 2004; Saitou and Nei, 1987). Bootstrap
evaluation of the branching pattern was performed with 100
replications.
Tropism analysis
The putative tropism of unique U3 sequences was deter-
mined by comparison to the reference sequences (direct repeats,
unique region) first reported by Tomonaga et al. (Tomonaga
and Coffin, 1998; Tomonaga and Coffin, 1999). A total of four
direct repeats (1/1⁎, 4/4⁎, 5/5⁎, and 6/6⁎), a single 190 bp
insertion, and two unique sequences (2 and 3) were utilized for
the tropism analysis.
Analysis of transcription regulatory elements
The 22 unique U3 sequences were analyzed for transcription
regulatory elements using the MatInspector program (Genoma-
tix, Munich, Germany). The core similarity was set to 0.9 and
the matrix similarity was optimized within the vertebrate matrix
group. The U3 sequences are organized in Table 2 to match the
order within the multiple alignment and phylogenetic tree.
In silico mapping and cloning of putative MuERVs
Putative MuERV sequences were identified by probing the
NCBI mouse genome database using the 22 unique U3 se-
quences with the NCBI Megablast program. The key reference
for identifying viral sequences of interest was a 5–9 kb se-
quence region flanked by LTRs, which harbor U3 sequences.
The following parameters were used with the Megablast pro-
gram: in the options section “NC_000067:NC_000087” was
272 Y.-K. Lee et al. / Virology 373 (2008) 263–273entered into the “limited by entrez query” field. The filters were
set to none while the percent identity, match, mismatch scores
were set to 98, 1, and −3, respectively.
MuERV provirus nomenclature
The putative MuERV proviruses were named after the U3
probes/sequences used in Megablast (e.g., Th(I)-2), followed by
the percentage homology of the blast hits (e.g., Th(I)-2 99%).
The letters following the U3 probe/sequence (e.g., Th(I)-2a
99%) are to differentiate multiple hits found using the U3 probe
with similar blast percentage hits.
ORF analysis
The ORFs of each putative MuERV were analyzed using
the ORF search feature within Vector NTI (Invitrogen). The
parameterswere set at aminimumof 50 codonswith “ATG” as the
start codon, and each candidate ORF was translated. The amino
acid translations were then compared using Vector NTI AlignX
(Invitrogen) to the following MuLV references retrieved from
NCBI (GenBank accession nos. M17327, AY219567.2,
AA037285, DQ241301, and AF033811). The criteria for defin-
ing the intactness of each proviral gene depended on the p12
region of gag, RT (reverse transcriptase) of pol and SU (surface
domain) of env. Proviral genes were deemed intact (+) if the
aforementioned sequences were intact and the remaining amino
acid sequence of each respective gene matched one of the refer-
ence sequences, while allowing for missense mutations. Proviral
genes were classified as partial (p) if the defining sequences were
intact but the remaining proviral gene sequences were defec-
tive. Defective (−) proviral gene sequences contained amino acid
deletions and premature stop codons in addition to improper start
codons leading to defective defining coding sequences.
Integration age and recombination event
5′ and 3′ LTR sequences of the putative MuERVs were
compared using the Vector NTI AlignX program (Invitrogen).
The integration age was calculated based on a formula of “0.13%
mutation rate between two flanking LTRs per one MYr”. In case
there is only a single nucleotide difference between two flanking
LTRs, its integration age is recorded as less than the estimated
age in consideration of potential error during cloning and
sequencing. To examine the genomic rearrangement between
MuERVs as well as with other parts of the genome, a short
stretch of sequences (4 bp to 12 bp) flanking each MuERV was
surveyed for a direct repeat, which is formed during the initial
proviral integration.
PBS analysis
A stretch of 18 bp, located immediately downstream of the
5′ U5 region, was examined to determine PBSs for the putative
MuERVs. The conserved PBS sequences for tRNAProline (P) and
tRNAGlutamine (Q) were used as references (Harada et al., 1979;
Nikbakht et al., 1985).RFLP tropism analysis of full-length MuERVs
Tropism of the putative full-length MuERVs was determined
by in silico RFLP analysis using three restriction enzymes,
BamHI, EcoRI, and HindIII, using Vector NTI (Invitrogen).
The RFLP data of each putative MuERV were compared to the
reference profiles for each tropism (ecotropic, xenotropic, poly-
tropic, and modified polytropic) reported previously (Stoye and
Coffin, 1988).
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